Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion type Assertion NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_head.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion description "[The vast majority of FTLD and ALS are characterized by the abnormal accumulation of TDP-43, including genetic forms associated with mutations in the genes C9ORF72, GRN, TARDBP and VCP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_provenance.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion evidence source_evidence_literature NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_provenance.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion SIO_000772 24011641 NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_provenance.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion wasDerivedFrom befree-20150227 NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_provenance.
- NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_assertion wasGeneratedBy ECO_0000203 NP433940.RAXQ11sSi60ERXdRJ5DsJrFTErHhcyVpSyIAw4RGt-aI0130_provenance.